The result of TargetScan prediction for the binding sites of fhe-mir-125b-5 in the 3'-UTR of TRAF6, MAP2K7, and STAT3 molecules indicates that fhe-miR-125b binds to inflammation or IBD-related target genes, including TRAF6, MAP2K7, and STAT3, to exert immune suppression effects, which has potential for the treatment of IBD.

fhe-miR-125b 抑制炎症和IBD:靶向TRAF6、MAP2K7和STAT3

原文地址: https://www.cveoy.top/t/topic/ncru 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录